Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies

Authors :: Paolo Abada
Takuji Okusaka
Markus Peck-Radosavljevic
Lee Bowman
David Cella
Masatoshi Kudo
Allicia C. Girvan
J.-F. Blanc
Yanzhi Hsu
Richard S. Finn
I. Chau
Ivan Borbath
Andrew X. Zhu
Josep M. Llovet
Peter R. Galle
J. Gable
Source :: Zeitschrift für Gastroenterologie.
Publication Year :: 2019
Publisher :: Georg Thieme Verlag KG, 2019.

Subjects :: medicine.medical_specialty
Pooled analysis
business.industry
Hepatocellular carcinoma
Internal medicine
medicine
Cancer
In patient
medicine.disease
Alpha-fetoprotein
business
Gastroenterology

Full Text Access

Tools